NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Santa Ana Bio

Santa Ana Bio

Private
Alameda, CaliforniaHealthcare & Life Scienceshttps://www.santaana.bio/

Last Round

Series A

Jun 13, 2024

Total Funding Raised

$211M

Company Overview

Santa Ana Bio is a biotechnology company that develops precision immunology solutions for autoimmune and inflammatory diseases using single-cell genomics and advanced analytics to create targeted biologics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

precision medicinedrug discoverybiotechnologyautoimmune diseasebiologicsmulti-omicstherapeutic developmentinflammatory diseasedrug pipelinebiotech startuppreclinical researchmonoclonal antibodiesbispecificsADCantibody-drug conjugatesclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Santa Ana Bio Comparables

Compare Santa Ana Bio with similar companies based on industry and business-model similarity.

Santa Ana Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beeline Medicines
86%
Lifordi Immunotherapeutics, Inc.
83%
Mirador Therapeutics
83%

Santa Ana Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 13, 2024
Series BJun 13, 2024
Series AFeb 1, 2023

Santa Ana Bio Investors

Notable investors and investment history

Santa Ana Bio investors
InvestorRounds
Andreessen HorowitzSeries B
GVSeries A, Series B
Versant VenturesSeries B, Series A
RTW InvestmentsSeries B
Access BiotechnologySeries B
TPGSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 13, 2024

    $43M round led by Versant Ventures

  • Jun 13, 2024

    $125M round led by GV

Santa Ana Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Santa Ana Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Santa Ana Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersAlameda, California
Employee Range35
Year Founded2020
Last FundingJun 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.